Answers are grounded in this paper and cite their sources.
Observational analysis demonstrates covert memory impairment linked to microglial activation in preclinical Alzheimer’s cases, suggesting early cognitive risks.
Microglial activation was significantly raised in preclinical AD cases with no cognitive complaints and associated with impaired memory test performance. This suggests that microglial activation is present before overt clinical symptoms emerge and may be detrimental to cognition even at this early stage.
No takes yet. Share an insight, caveat, or question.
Kjeldsen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: